WASHINGTON: US biotech firm Moderna on Wednesday announced initial data from a small clinical trial that showed its booster shots improved people’s immune responses against key coronavirus variants of concern.
© New Straits Times Press (M) Bhd

WASHINGTON: US biotech firm Moderna on Wednesday announced initial data from a small clinical trial that showed its booster shots improved people’s immune responses against key coronavirus variants of concern.
© New Straits Times Press (M) Bhd